Concepedia

Author

Reynaldo Garcia

University of North Carolina at Chapel Hill

Also Known As

R Arteaga García, R. A. Garcia, Reynaldo A. Garcia, Reynaldo Garcia

13

Publications

455

Citations

6

H-Index

6

Concepts

All Affiliations

University of North Carolina at Chapel Hill
RG

About

Reynaldo Garcia is an author at University of North Carolina at Chapel Hill specializing in health sciences, pathology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

46

2

Medicine

1

1

46

3

Pathology

1

1

46

4

Hematology

1

1

46

5

Oncology

1

1

46

Reynaldo Garcia

×

5

Publications

428

Citations

5

H-Index

YearCitations

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia,

Blood

2004

319

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

Suzanne E. Biehn, Dominic T. Moore, Peter M. Voorhees,

Annals of Hematology

2006

46

Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma.

Hanna K. Sanoff, Stephen A. Bernard, Richard M. Goldberg,

PubMed

2011

42

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Peter M. Voorhees, Cristina Gasparetto, Kristy L. Richards,

Blood

2009

11

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

Raoul Tibes, Kevin T. McDonagh, Lazaros J. Lekakis,

Blood

2009

10

Page 1